Home » Newsletters » BioWorld Science

BioWorld Science

March 30, 2015

View Archived Issues

Remotely regulated gene exression system devised to study disease

New NaV1.7 inhibitor identified for the treatment of pain

Sigma-Tau products granted FDA orphan status

Elafin shows potential as a biomarker to distinguish GVHD from EM

Researchers identify INSM1 as a sensitive marker of MCC

FDA gives ganaxolone orphan status for PCDH19 female epilepsy

University of Illinois patent describes new antimicrobials

Bristol-Myers Squibb presents PD-1/PD-L1 interaction inhibitors

Oxford Pharmascience reports topline data from pilot study of OXPzero Naproxen

Toray describes highly potent alpha1L-adrenoceptor agonists

100,000 Genomes Project aims to accelerate the development of new diagnostics and treatments

Novel GPBAR1 agonists synthesized for the treatment of diabetes and metabolic syndrome

ZeClinics seeks investment to develop zebra fish-based ZeOncoTest

Shire and Cincinnati Children's Hospital Medical Center to collaborate on rare disease therapies

Aldeyra Therapeutics starts phase II trial of NS-2 for non-infectious anterior uveitis

Japanese approval for Lenvima for unresectable thyroid cancer

Aduro BioTech cancer vaccine given orphan status for mesothelioma

Avalanche Biotechnologies and University of Washington collaborate to treat color blindness

Apceth begins phase II trial of engineered cell therapy to treat gastrointestinal cancer

Positive outcome from European decentralized procedure for approval of Soolantra for rosacea

Synflorix obtained Japanese approval as a pediatric pneumococcal conjugate vaccine

AG-348 assigned orphan status for pyruvate kinase deficiency

Aurigene discloses PD-1 inhibitors

Medivir present HCV polymerase NS5B inhibitors

Korean researchers describe new HGFR inhibtors

Genfit releases topline data from phase IIb study of GFT-505 for NASH

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...